Related Experiment Video
Updated: Mar 21, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Emerging factors in the progression of cancer-related pain
David K Lam1,2,3,4
1Oral & Maxillofacial Surgery, University of Toronto, Toronto, ON, Canada.
Abstract:
Most cancer patients experience severe pain during their disease course, and the management of cancer pain is a major challenge for patients and the healthcare team. Many diverse translational models of cancer pain in recent years have improved our understanding of cancer-related pain. Cancer and associated cells in the cancer microenvironment may release various peripheral mediators, including ATP, formaldehyde, protons, proteases, endothelin, bradykinin, TNF and NGF, that result in the activation and/or sensitization of peripheral and central neurons, that contribute to the clinical manifestations of cancer-related pain. Identification of these mediators and the peripheral and central mechanisms by which they contribute to cancer-related pain may provide novel therapeutic targets to alleviate cancer patient suffering.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Nociception
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Pain
Mitogens and the Cell Cycle

